Cerebral microbleeds (CMBs) may increase the risk of recurrent stroke and mortality in patients who have recently experienced an embolic stroke of undetermined source (ESUS), according to subgroup analyses of the phase III NAVIGATE ESUS* trial.
High doses of parenteral lipids during the first week of life eases aggressive weight loss among very low birthweight (VLBW) infants, a new study has found. This feeding regimen may also protect against extra-uterine growth restrictions.
Adding the CDK4/6 inhibitor abemaciclib to an endocrine therapy of fulvestrant extends overall survival (OS) compared with fulvestrant alone in East Asian patients with hormone receptor-positive (HR+), HER2-negative advanced breast cancer (ABC) who have progressed on prior endocrine therapy, consistent with results from the overall population, updated analysis of the global, phase III MONARCH 2 study has shown.
The interleukin (IL)-1β antibody canakinumab has demonstrated a promising efficacy signal in patients with COVID-19-related pneumonia, reducing the need for invasive mechanical ventilation and improving clinical status, according to a study.
Renin-angiotensin system inhibitors perform better than calcium channel blockers (CCB) at decreasing albuminuria among diabetic and hypertensive patients with nephropathy, according to the results of a systematic review and meta-analysis.
Ablative radiotherapy for new primaries leads to improved overall survival (OS) compared with initial lung cancer stereotactic body radiation therapy (SBRT) in inoperable patients, a recent study has shown.
The RetinaScope, a smartphone-based camera, paired with an artificial intelligence (AI) screening system called EyeAlert, can match and even outperform experts at determining the presence of referral-warranted diabetic retinopathy (RWDR), according to a recent study.
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa,
08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.